Norges Bank’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,255,148
Closed -$133M 435
2025
Q4
$133M Buy
+1,255,148
New +$145M 0.01% 646
2025
Q3
Sell
-1,137,860
Closed -$140M 489
2025
Q2
$140M Buy
1,137,860
+31,663
+3% +$3.62M 0.02% 588
2025
Q1
$112M Buy
1,106,197
+16,464
+2% +$1.61M 0.02% 629
2024
Q4
$101M Sell
1,089,733
-59,632
-5% -$5.85M 0.01% 677
2024
Q3
$111M Buy
1,149,365
+10,799
+0.9% +$970K 0.02% 643
2024
Q2
$97.7M Buy
1,138,566
+19,294
+2% +$1.62M 0.01% 641
2024
Q1
$92.4M Buy
1,119,272
+82,429
+8% +$6.04M 0.01% 675
2023
Q4
$69.2M Buy
1,036,843
+39,418
+4% +$2.55M 0.01% 754
2023
Q3
$67M Buy
997,425
+22,658
+2% +$1.56M 0.01% 714
2023
Q2
$66M Sell
974,767
-28,428
-3% -$1.78M 0.01% 729
2023
Q1
$54.3M Buy
1,003,195
+16,938
+2% +$986K 0.01% 797
2022
Q4
$59M Buy
986,257
+58,580
+6% +$3.19M 0.01% 743
2022
Q3
$42M Sell
927,677
-201,036
-18% -$10.1M 0.01% 847
2022
Q2
$50.3M Buy
1,128,713
+17,530
+2% +$899K 0.01% 774
2022
Q1
$62.9M Sell
1,111,183
-79,064
-7% -$4.13M 0.01% 765
2021
Q4
$61.8M Buy
1,190,247
+43,309
+4% +$2.23M 0.01% 826
2021
Q3
$68.5M Sell
1,146,938
-42,461
-4% -$2.67M 0.02% 777
2021
Q2
$73.8M Sell
1,189,399
-37,995
-3% -$2.53M 0.02% 765
2021
Q1
$80M Buy
1,227,394
+108,961
+10% +$7.11M 0.02% 728
2020
Q4
$73.6M Buy
1,118,433
+21,835
+2% +$1.28M 0.02% 739
2020
Q3
$56.7M Sell
1,096,598
-432,059
-28% -$22.2M 0.02% 774
2020
Q2
$75.3M Sell
1,528,657
-170,259
-10% -$9.19M 0.02% 625
2020
Q1
$86.5M Sell
1,698,916
-8,760
-0.5% -$505K 0.03% 480
2019
Q4
$94.1M Sell
1,707,676
-6,499
-0.4% -$353K 0.03% 570
2019
Q3
$86.3M Hold
1,714,175
0.03% 576
2019
Q2
$86.4M Sell
1,714,175
-20,963
-1% -$1.02M 0.03% 577
2019
Q1
$80.6M Hold
1,735,138
0.03% 582
2018
Q4
$85.2M Hold
1,735,138
0.03% 499
2018
Q3
$108M Hold
1,735,138
0.03% 467
2018
Q2
$93.5M Sell
1,735,138
-17,589
-1% -$879K 0.03% 511
2018
Q1
$79.7M Hold
1,752,727
0.03% 569
2017
Q4
$68.9M Sell
1,752,727
-196,581
-10% -$7.48M 0.02% 621
2017
Q3
$71.9M Buy
1,949,308
+195,676
+11% +$6.97M 0.03% 578
2017
Q2
$67.5M Buy
1,753,632
+183,912
+12% +$6.73M 0.03% 593
2017
Q1
$53.5M Buy
1,569,720
+215,935
+16% +$7.09M 0.02% 669
2016
Q4
$44.4M Buy
1,353,785
+325,862
+32% +$10.6M 0.02% 738
2016
Q3
$31.7M Sell
1,027,923
-51,023
-5% -$1.65M 0.02% 904
2016
Q2
$33.3M Hold
1,078,946
0.02% 862
2016
Q1
$32.3M Buy
1,078,946
+42,945
+4% +$1.19M 0.02% 861
2015
Q4
$28.7M Sell
1,036,001
-31,425
-3% -$894K 0.01% 917
2015
Q3
$32.6M Sell
1,067,426
-2,136
-0.2% -$74.4K 0.02% 822
2015
Q2
$39.2M Hold
1,069,562
0.02% 775
2015
Q1
$37.7M Hold
1,069,562
0.02% 810
2014
Q4
$32.7M Buy
1,069,562
+47,522
+5% +$1.48M 0.02% 878
2014
Q3
$30M Sell
1,022,040
-1,022,041
-50% -$31.2M 0.02% 876
2014
Q2
$58.3M Buy
2,044,081
+973,164
+91% +$27.1M 0.02% 908
2014
Q1
$30.6M Hold
1,070,917
0.02% 853
2013
Q4
$28.4M Hold
1,070,917
0.02% 879
2013
Q3
$29.4M Hold
1,070,917
0.02% 844
2013
Q2
$24.5M Buy
+1,070,917
New +$24.2M 0.02% 886

Other funds holding EHC

Norges Bank's EHC Position: Q1 2026 in Review

Norges Bank sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 1,255,148 shares — an estimated $133M sold.

Norges Bank first reported a position in EHC in Q2 2013 and held it in 50 quarters. The position peaked at $140M in Q2 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Norges Bank reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Norges Bank sold 1,255,148 Encompass Health shares in Q1 2026, an estimated $133M.
  • Norges Bank first reported a position in Encompass Health in Q2 2013 and held it in 50 quarters.
  • Norges Bank's Encompass Health position peaked at $140M in Q2 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.